The store will not work correctly when cookies are disabled.
N-(1-methylcyclopropyl)-2-(2H-1,2,3,4-tetrazol-5-yl)pyrido[3,4-d]pyrimidin-4-amine
ID: ALA4514307
PubChem CID: 137350640
Max Phase: Preclinical
Molecular Formula: C12H12N8
Molecular Weight: 268.28
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC1(Nc2nc(-c3nn[nH]n3)nc3cnccc23)CC1
Standard InChI: InChI=1S/C12H12N8/c1-12(3-4-12)16-9-7-2-5-13-6-8(7)14-10(15-9)11-17-19-20-18-11/h2,5-6H,3-4H2,1H3,(H,14,15,16)(H,17,18,19,20)
Standard InChI Key: VBRSIZGFUHKGKX-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 23 0 0 0 0 0 0 0 0999 V2000
4.4863 -11.2632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8990 -10.5575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0815 -10.5529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0390 -13.4217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1318 -14.2312 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9318 -14.3980 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4861 -12.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4849 -13.0237 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1971 -13.4327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1953 -11.7871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9081 -12.1965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9088 -13.0196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6215 -13.4267 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3298 -13.0158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3250 -12.1896 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6159 -11.7821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6116 -10.9608 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8901 -9.7431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7784 -13.0853 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3350 -13.6905 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
1 3 1 0
4 5 1 0
5 6 2 0
6 20 1 0
19 4 2 0
7 8 2 0
8 9 1 0
9 12 2 0
11 10 2 0
10 7 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
16 17 1 0
14 4 1 0
17 2 1 0
2 18 1 0
19 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 268.28 | Molecular Weight (Monoisotopic): 268.1185 | AlogP: 1.17 | #Rotatable Bonds: 3 |
Polar Surface Area: 105.16 | Molecular Species: ACID | HBA: 7 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.88 | CX Basic pKa: 3.42 | CX LogP: 1.52 | CX LogD: 0.15 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.73 | Np Likeness Score: -0.96 |
References
1. (2018) 6-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS Inhibitors, |